Group 1 - Senyuan Electric signed a strategic cooperation agreement with Xuchang Digital Supply Chain Management Co., aiming for annual business cooperation not exceeding 500 million yuan over 36 months [1] - CICC's subsidiary, CICC Wealth, reported a net profit of 987 million yuan for the first half of the year, with total assets of 193.37 billion yuan [2] - Shuangjie Electric expects a net profit of 100 million to 120 million yuan for the first half of the year, representing a year-on-year increase of 16.03% to 39.23% [3][4] - Shentong Technology reported a net profit of 64.28 million yuan for the first half of the year, a year-on-year increase of 111.09% [5] - Suqian Nongfa's net profit for the first half of the year decreased by 27.72% to 213 million yuan [6] Group 2 - Fuan Pharmaceutical expects a net profit decline of 39.95% to 53.81% for the first half of the year, estimating between 100 million to 130 million yuan [8] - Xingwang Yuda anticipates a net loss of 11 million to 21 million yuan for the first half of the year [9] - Pulaike received a new veterinary drug registration certificate for a vaccine aimed at preventing chicken diseases [10] - Yuandong Biological's ephedrine injection received a drug registration certificate for treating low blood pressure during anesthesia [11] - Suqian Liansheng's subsidiary obtained two invention patent certificates [12] Group 3 - Oke Technology signed a 176 million yuan equipment order with Jiangxi Tianhong New Materials [13] - Publishing Media announced the resignation of its chief accountant due to work changes [15] - Zhongxin Co. plans to use 40 million yuan of idle funds for cash management [16] - Huiyun Titanium plans to use up to 58 million yuan of idle convertible bond funds for cash management [18] - Haineng Technology intends to apply for a credit facility of up to 200 million yuan from a bank [20] Group 4 - Jiabiou expects a net profit increase of 57.61% for the first half of the year, estimating around 107 million yuan [21] - Nanjing Gaoke reported a 1185% year-on-year increase in contract sales area for the second quarter [22] - Shuguang Co. received approval for a specific stock issuance application [23] - Huadong Pharmaceutical's subsidiary received approval for a clinical trial of a new drug targeting advanced solid tumors [23] - Quicheng Co. plans to invest 900 million yuan in two new projects [25] Group 5 - Shenlian Biological's vaccine for avian adenovirus received a new veterinary drug registration certificate [26] - Rike Chemical signed a strategic cooperation framework agreement with Dongming Petrochemical [28] - Jincheng Pharmaceutical's subsidiary received a renewed tobacco production license [29] - Magmi Te's stock issuance application was accepted by the Shenzhen Stock Exchange [29] - Zhongyin Securities received approval to issue bonds totaling up to 14 billion yuan [29] Group 6 - Hewei Electric's executives plan to reduce their holdings by a total of 2.24% of the company's shares [44] - Guo Wang Xintong reported a net profit of 266 million yuan for the first half of the year, a decrease of 10.82% [45] - Guo Wang Xintong's subsidiary won a 966 million yuan tender from the State Grid [46] - Jicheng Electronics won contracts worth approximately 83.79 million yuan from the State Grid [48] - Helen Piano is planning a change of control, leading to a temporary stock suspension [48]

Core Viewpoint - Tianjin Jinbin Development Co., Ltd. has announced its profit distribution plan for the fiscal year 2024, which includes a cash dividend of RMB 0.95 per 10 shares, totaling approximately RMB 153.64 million, with no stock dividends or capital reserve transfers planned [2][3]. Summary by Sections Profit Distribution Plan - The profit distribution plan was approved at the annual shareholders' meeting held on May 29, 2025, based on a total share capital of 1,617,272,234 shares as of December 31, 2024 [2]. - A cash dividend of RMB 0.95 per 10 shares will be distributed, amounting to a total of RMB 153,640,862.23, with the remaining profit retained as undistributed profit [3]. Dividend Implementation Details - The distribution will not change even if the company's share capital changes between the announcement and the implementation of the distribution plan [3]. - The implementation of the distribution plan will occur within two months of the shareholders' meeting approval [3]. Taxation and Dividend Distribution Method - For Hong Kong market investors and certain foreign institutions, the cash dividend will be RMB 0.855 per 10 shares after tax [3]. - Different tax rates will apply to individual shareholders based on their holding periods, with specific tax amounts outlined for different durations [4]. Shareholder Registration and Payment - The record date for the dividend distribution is set for July 25, 2025, and the ex-dividend date will follow [5]. - Cash dividends will be directly credited to shareholders' accounts through their custodial securities companies on July 28, 2025 [5].

证券简称：津滨发展 证券代码：000897 编号：2025-15 天津津滨发展股份有限公司 2024 年年度权益分派实施公告 一、股东大会审议通过利润分配及资本公积金转增股本方案等情 况： （一）公司 2024 年度股东大会审议通过的利润分配方案具体为： 以 2024 年 12 月 31 日的公司总股本 1,617,272,234 股为基数，向全 体股东每 10 股派发现金股利人民币 0.95 元（含税），共计派发现金 人民币 153,640,862.23 元（含税），剩余利润作为未分配利润留存； 本年度不送红股，不以公积金转增股本。若公司股本在分配预案披露 后至分配方案实施前，公司股本发生变动的，公司维持分配总额不变， 相应调整每股分配金额。 （二）自分配预案披露至分配方案实施期间，公司股本总额未发 生变化。 （三）本次实施的分配方案与股东大会审议通过的分配方案一致。 （四）本次权益分派实施距离股东大会审议通过的时间未超过两 个月。 二、权益分派方案 公 司 2024 年年度权益分派方案为：以公司现有总股本 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 天 ...

本业绩预告未经注册会计师预审计。公司已就本次业绩预告有关事项与会计 师事务所进行了预沟通，公司与会计师事务所在本报告期的业绩预告财务数据方 面不存在重大分歧。 三、业绩变动的主要原因说明 公司2025年半年度业绩较上年同期减少的主要原因是，本报告期无新增可结 算项目，房地产项目结算收入较上年同期减少所致。 四、风险提示 证券代码：000897 证券简称：津滨发展 公告编号：2025-14 天津津滨发展股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没 有虚假记载、误导性陈述或重大遗漏。 一、本期业绩预计情况 金额币种：人民币 项目 本报告期 上年同期 归属于上市公司 盈利：0 万元 - 500 万元 盈利：33,184.13 万元 股东的净利润 比上年同期减少：98.49% - 100% 扣除非经常性损 盈利：0 万元 - 500 万元 盈利：33,206.03 万元 益后的净利润 比上年同期减少：98.49% - 100% 基本每股收益 盈利：0 - 0.0031 元/股 盈利：0.2052 元/股 二、业绩预告预审计情况 本公司指定的信息披露媒体为《中国证券报》、《证券时报》和巨潮 ...

津滨发展（000897）公告，预计2025年1月1日至2025年6月30日归属于上市公司股东的净利润为0万 元-500万元，比上年同期的3.32亿元减少98.49%-100%。 ...

证券代码：000897 证券简称：津滨发展 公告编号：2025-14 天津津滨发展股份有限公司 2025 年半年度业绩预告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没 有虚假记载、误导性陈述或重大遗漏。 一、本期业绩预计情况 1．业绩预告期间：2025 年 1 月 1 日 – 2025 年 6 月 30 日 2. 预计的业绩：同向下降 金额币种：人民币 | 项目 | 本报告期 | | | | | | 上年同期 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 归属于上市公司 | 盈利：0 - | 万元 | | 500 | 万元 | | 盈利：33,184.13 | 万元 | | 股东的净利润 | 比上年同期减少：98.49% - | | | | | 100% | | | | 扣除非经常性损 | 盈利：0 - | 万元 | | 500 | 万元 | | 盈利：33,206.03 | 万元 | | 益后的净利润 | 比上年同期减少：98.49% - | | | | | 100% | | | | 基本每股收益 | 盈利：0 ...

Market Performance - As of June 6, the Tianjin Free Trade Zone concept index rose by 2.60%, ranking second among concept sectors, with seven stocks increasing in value [1] - Notable gainers included HNA Technology, Bohai Chemical, and Haitai Development, which hit the daily limit, while HNA Technology, Tianjin Pulin, and Youfa Group saw increases of 9.03%, 2.68%, and 1.56% respectively [1] Sector Comparison - The Tianjin Free Trade Zone concept was among the top-performing sectors, with a net inflow of 120 million yuan from main funds, indicating strong investor interest [2] - The leading stocks in terms of net fund inflow were HNA Technology, Bohai Chemical, and Jintou City Development, with net inflows of 90.06 million yuan, 86.73 million yuan, and 47.65 million yuan respectively [2] Fund Flow Analysis - The net inflow ratios for Haitai Development, Jintou City Development, and Bohai Chemical were 51.10%, 20.62%, and 14.08% respectively, indicating significant investor confidence in these stocks [3] - The detailed fund flow data showed that HNA Technology had a trading volume of 90.06 million yuan with a turnover rate of 9.89%, while Bohai Chemical had a turnover rate of 13.09% [3][4]

天津经济技术开发区第二大街62号泰达MSD-B2座306 Tel: 86-22-25326960 25326966 25326759 25326760 Fax: 86-22-25326959 PC:300457 天津市南开区水上公园北道鲁能国际中心10层1019-1020 Tel:86-22-87192100 87192101 Fax: 86-22-25326959 Http://www.tedalawfirm.com E-mail: teda@tedalawfirm.com 天津津滨发展股份有限公司 2024 年年度股东大会 法 律 意 见 书 致：天津津滨发展股份有限公司 根据《中华人民共和国公司法》（以下简称"公司法"）、《中华人民共 和国证券法》（以下简称"证券法"）、《上市公司股东大会规则》（以下简 称"股东大会规则"）、《深圳证券交易所上市公司自律监管指引第 1 号— —主板上市公司规范运作（2023 年 12 月修订）》、《深圳证券交易所上市 公司股东大会网络投票实施细则》（以下简称"《股东大会网络投票实施细 则》"）及深圳证券交易所《关于修改部分业务规则和业务指南的通知》， 以及《天津津滨发展 ...

天津津滨发展股份有限公司 证券代码：000897 公司简称：津滨发展 公告编号：2025-13 ●本次股东大会无增加、修改议案的情形；未出现否决提案的情形。 ●本次股东大会无涉及变更以往股东大会已通过的决议。 ●本次会议以现场投票和网络投票相结合的方式召开。 ●为尊重中小投资者利益，本次股东大会所提议案均对中小投资者的表决单独计票。 一、会议召开和出席情况 1、会议召开情况 （1）现场会议时间：2025 年 5 月 29 日下午 14:00 （2）网络投票时间：2025 年 5 月 29 日。其中，通过深交所交易系统进行网络投票的具 体时间为 2025 年 5 月 29 日 9:15～9:25，9:30～11:30，13:00～15:00；通过深交所互联网 投票系统投票的具体时间为 2025 年 5 月 29 日 9:15～15:00 期间的任意时间。 2024年度股东大会决议公告 本公司及董事全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述 或重大遗漏。 重要内容提示： （3）召开地点：天津市干部俱乐部内八号楼会议室 （4）召开方式：现场投票和网络投票相结合的方式； （5）召集人：董事会 ...

天津津滨发展股份有限公司 独立董事 2024 年度述职报告 （岳子奇） 本人作为天津津滨发展股份有限公司（以下简称"公司"）的独立董事， 能够严格按照《公司法》、《上市公司治理准则》、《上市公司独立董事管理 办法》、《公司章程》、公司《独立董事工作制度》等有关法律法规和规章制 度的规定和要求，秉承勤勉和尽职的态度，积极出席公司召开的各类会议，认 真审议各项议案并独立、客观、公正地对相关事项发表意见。积极有效地履行 了独立董事的职责，维护了公司和中小股东的合法权益。现将本人 2024 年度 履行职责情况报告如下： 一、基本情况 本人岳子奇,现任天津银丰集团有限公司董事长。曾任天津银丰公司董事长 。自 2024年8月起至今担任天津津滨发展股份有限公司（以下简称"公司"） 独立董事。 2、行使独立董事职权的情况 2024 年，本人未发生独立聘请中介机构的情况；未发生向董事会提议召开 临时股东大会的情况；未发生提议召开董事会的情况；未发生依法公开向股东 征集股东权利的情况；不存在可能损害上市公司或者中小股东权益的事项。 3、与审计机构进行沟通的情况 本人未在公司担任除独立董事以外的任何职务，也未在公司主要股东公司 担 ...